ES2196148T3 - (hipersvirus) recombinado y utilizacion de un promotor de gen gb. - Google Patents

(hipersvirus) recombinado y utilizacion de un promotor de gen gb.

Info

Publication number
ES2196148T3
ES2196148T3 ES96914457T ES96914457T ES2196148T3 ES 2196148 T3 ES2196148 T3 ES 2196148T3 ES 96914457 T ES96914457 T ES 96914457T ES 96914457 T ES96914457 T ES 96914457T ES 2196148 T3 ES2196148 T3 ES 2196148T3
Authority
ES
Spain
Prior art keywords
promoter
gen
gene
hipersvirus
recombination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96914457T
Other languages
English (en)
Inventor
Kengo Sonoda
Masashi Sakaguchi
Kazuo Matsuo
Fukusaburo Hamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of ES2196148T3 publication Critical patent/ES2196148T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

UN HERPESVIRUS RECOMBINANTE CAPAZ DE EXPRESAR DE FORMA EFICAZ LA PROTEINA EXTRAÑA DIANA EN UN ANIMAL HUESPED QUE HA SIDO INOCULADO CON LA MISMA Y QUE EJERCE UN EXCELENTE EFECTO INMUNOLOGICO. EL HERPESVIRUS RECOMBINANTE TIENE UN ENVASE DE EXPRESION DE GEN EXTRAÑO INTEGRADO EN EL MISMO EN DONDE UN GEN GB QUE ORIGINA UN PROMOTOR DE HERPESVIRUS (UN GEN HOMOLOGO CON EL GEN HERPES SIMPLEX VIRUS GB) SE EMPLEA COMO UN PROMOTOR PARA LA EXPRESION DEL GEN EXTRAÑO.
ES96914457T 1995-06-02 1996-05-28 (hipersvirus) recombinado y utilizacion de un promotor de gen gb. Expired - Lifetime ES2196148T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7160106A JPH08322559A (ja) 1995-06-02 1995-06-02 ｇＢ遺伝子プロモーターを用いた組換えヘルペスウイルス

Publications (1)

Publication Number Publication Date
ES2196148T3 true ES2196148T3 (es) 2003-12-16

Family

ID=15707989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96914457T Expired - Lifetime ES2196148T3 (es) 1995-06-02 1996-05-28 (hipersvirus) recombinado y utilizacion de un promotor de gen gb.

Country Status (11)

Country Link
US (1) US6013261A (es)
EP (1) EP0774513B1 (es)
JP (2) JPH08322559A (es)
CN (1) CN1155710C (es)
AT (1) ATE236254T1 (es)
AU (1) AU692395B2 (es)
BR (1) BR9606412A (es)
CA (1) CA2196416C (es)
DE (1) DE69627109T2 (es)
ES (1) ES2196148T3 (es)
WO (1) WO1996038565A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410222B1 (en) 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
HUP9802974A1 (hu) * 1998-12-19 2000-09-28 Mezőgazdasági Biotechnológiai Kutatóközpont Fertőző bursitis elleni DNS-vakcina
US6764684B2 (en) * 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
CN100510082C (zh) * 2007-06-18 2009-07-08 扬州大学 一种淋巴组织特异性基因表达调控序列
CN103235127A (zh) * 2013-04-17 2013-08-07 河南省农业科学院 马立克氏病病毒快速检测试纸条
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
JP6679484B2 (ja) * 2013-12-11 2020-04-15 ザ ヘンリー エム． ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド ヒトヘルペスウイルス三量体糖タンパク質Ｂ、三量体ｇＢを含むタンパク質複合体、及びワクチンとしてのそれらの使用
WO2025201387A1 (en) * 2024-03-27 2025-10-02 Boehringer Ingelheim Vetmedica (China) Co., Ltd. A recombinant serotype 1 marek's disease virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2583115B2 (ja) * 1988-09-10 1997-02-19 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
US5558860A (en) * 1988-09-13 1996-09-24 Rhone Merieux Viral vaccines
EP0434721B1 (en) * 1988-09-13 2000-03-15 Merial Viral nucleotide sequences
JP3428666B2 (ja) * 1991-07-09 2003-07-22 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
US5659153A (en) * 1995-03-03 1997-08-19 International Business Machines Corporation Thermoformed three dimensional wiring module

Also Published As

Publication number Publication date
CN1159209A (zh) 1997-09-10
MX9700870A (es) 1997-09-30
US6013261A (en) 2000-01-11
CN1155710C (zh) 2004-06-30
BR9606412A (pt) 1997-09-30
EP0774513A4 (en) 1999-10-13
WO1996038565A1 (en) 1996-12-05
EP0774513A1 (en) 1997-05-21
DE69627109D1 (de) 2003-05-08
ATE236254T1 (de) 2003-04-15
AU5780796A (en) 1996-12-18
CA2196416C (en) 2011-03-08
JPH08322559A (ja) 1996-12-10
EP0774513B1 (en) 2003-04-02
JP3933689B2 (ja) 2007-06-20
DE69627109T2 (de) 2003-12-18
CA2196416A1 (en) 1996-12-05
AU692395B2 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
ES2056817T3 (es) Transformacion de trichoderma.
FI951038A0 (fi) Pitkänomaisella valaistusvälineellä ja heijastimilla varustettu valaisin
ES2061582T3 (es) Procedimiento para producir una proteina de factor viii:c humano recombinante.
ATE195347T1 (de) Methoden der erhöhung der sekretion von überexpremierten proteinen
MX166499B (es) Interferon recombinante inmune humano y composicion farmaceutica que lo incluye
DE69426564D1 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
YU79393A (sh) Terapeutska kombinacija
DK0757717T3 (da) Papillomavirusvacciner
ES2196148T3 (es) (hipersvirus) recombinado y utilizacion de un promotor de gen gb.
AU575588B2 (en) Extraction of human-y interferon of 18 kdalton using the protease inhibitor guanidine-hcp
DK289285D0 (da) Thymopentin analoge
ES8606885A1 (es) Un procedimiento para la produccion de un polipeptido
DK366783D0 (da) Fremgangsmade til fremstilling af et polypeptid med virkni pa immunsystemet
ES8102658A1 (es) Un metodo para mejorado para sujetar una lente de plastico- a un aparato de iluminacion.
GB730227A (en) Improvements connected with directional lighting units for aircraft runway systems
ES2060134T3 (es) Inhibidor de tejido de metaloproteasas (timp-2).
GB1245929A (en) Improvements in or relating to synthetic plastic lenses
MX9102647A (es) Nueva proteina capaz de inducir una respuesta inmunoprotectora contra la infeccion causada por toxoplasma gondii y para clonar y expresar un gen que codifica a la proteina.
ATE153379T1 (de) Expression von proteinsüssmitteln in hefe
ES2109487T3 (es) Analogos de tetrapeptidos parcialmente modificados y retroinvertidos de fragmentos de proteina c-reactiva.
BR9509876A (pt) Bomba e medidor de combustível iluminado por fibra ótica
ES2088371B1 (es) Procedimiento para la produccion en forma recombinante de antigenos de la glicoproteina ge de herpesvirus bovino tipo 1 y su uso en la diferenciacion serologica entre animales infectados y animales vacunados.
GB623435A (en) Improvements in and relating to lighting fittings
GB607923A (en) Improvements in and relating to light reflectors and deflectors
DK447784A (da) Immuninterferon